PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 132 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $397 | +19.6% | 11,470 | 0.0% | 0.03% | +12.0% |
Q1 2024 | $332 | +23.4% | 11,470 | -2.1% | 0.02% | +13.6% |
Q4 2023 | $269 | +37.9% | 11,720 | 0.0% | 0.02% | +29.4% |
Q3 2023 | $195 | -42.3% | 11,720 | -4.1% | 0.02% | -41.4% |
Q2 2023 | $338 | +20.3% | 12,220 | 0.0% | 0.03% | +11.5% |
Q1 2023 | $281 | -39.0% | 12,220 | -71.1% | 0.03% | -40.9% |
Q4 2022 | $461 | -99.9% | 42,220 | 0.0% | 0.04% | +22.2% |
Q3 2022 | $356,000 | +6.6% | 42,220 | 0.0% | 0.04% | +12.5% |
Q2 2022 | $334,000 | -36.5% | 42,220 | +90.0% | 0.03% | -23.8% |
Q1 2022 | $526,000 | -30.8% | 22,220 | 0.0% | 0.04% | -26.3% |
Q4 2021 | $760,000 | +92.9% | 22,220 | 0.0% | 0.06% | +72.7% |
Q3 2021 | $394,000 | -56.7% | 22,220 | +9.7% | 0.03% | -57.1% |
Q2 2021 | $909,000 | +57.8% | 20,250 | -9.0% | 0.08% | +45.3% |
Q1 2021 | $576,000 | +28.3% | 22,250 | 0.0% | 0.05% | +20.5% |
Q4 2020 | $449,000 | +3.2% | 22,250 | 0.0% | 0.04% | -6.4% |
Q3 2020 | $435,000 | +5.8% | 22,250 | -4.5% | 0.05% | -4.1% |
Q2 2020 | $411,000 | +147.6% | 23,300 | -0.9% | 0.05% | +104.2% |
Q1 2020 | $166,000 | 0.0% | 23,500 | 0.0% | 0.02% | +20.0% |
Q4 2019 | $166,000 | -41.1% | 23,500 | 0.0% | 0.02% | -44.4% |
Q3 2019 | $282,000 | -1.1% | 23,500 | 0.0% | 0.04% | -2.7% |
Q2 2019 | $285,000 | -3.4% | 23,500 | 0.0% | 0.04% | -9.8% |
Q1 2019 | $295,000 | +86.7% | 23,500 | 0.0% | 0.04% | +64.0% |
Q4 2018 | $158,000 | -43.2% | 23,500 | -13.0% | 0.02% | -34.2% |
Q3 2018 | $278,000 | +51.9% | 27,000 | -1.1% | 0.04% | +40.7% |
Q2 2018 | $183,000 | -54.4% | 27,300 | -41.5% | 0.03% | -55.0% |
Q1 2018 | $401,000 | -58.7% | 46,700 | 0.0% | 0.06% | -58.6% |
Q4 2017 | $971,000 | +229.2% | 46,700 | +179.6% | 0.14% | +202.1% |
Q3 2017 | $295,000 | – | 16,700 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 2,449,183 | $84,864,191 | 21.18% |
Cannon Global Investment Management, LLC | 69,900 | $2,422,035 | 11.28% |
ADAR1 Capital Management, LLC | 1,603,932 | $55,576,244 | 10.49% |
Checkpoint Capital L.P. | 355,000 | $12,300,750 | 7.42% |
Fairmount Funds Management LLC | 931,890 | $32,289,989 | 3.65% |
BVF INC/IL | 3,319,290 | $115,013,399 | 3.22% |
RTW INVESTMENTS, LP | 5,286,404 | $183,173,899 | 2.84% |
Kynam Capital Management, LP | 800,000 | $27,720,000 | 2.14% |
683 Capital Management, LLC | 604,449 | $20,944,158 | 1.58% |
Birchview Capital, LP | 48,000 | $1,663,200 | 1.54% |